Rationale. The SCOR is highly dependent upon the generation and maintenance of transgenic and hybrid transgenic mice for the study of lung development and repair. The Animal Core is designed to take advantage of established expertise in the generation of the transgenic mice for the study of lung disease and in gene ablation studies that will be required for SCOR projects. Likewise, maintenance of germ-free, wild-type and transgenic lines will be critical in supplying genotyped mice for the various projects. This core will both generate the new transgenic lines and gene targeted mice, as well as maintain breeding and genotype analysis for the transgenic mice as required for the individual projeCts and investigators. This Core will: 1) provide animal husbandry, breeding, tail clip, Southern blot, PCR analysis for the mouse lines required for the SCOR projects; 2) generate all new transgenic lines described in the protocols by pronuclear injection and gene targeting; 3) facilitate maintenance, breeding, surveillance of the animal models; 4) produce mice exposed to carefully defined concentrations of oxygen for study of lung injury and repair. The animals will be maintained in sterile-barrier caging in a germ-free facility at the Children's Hospital Research Foundation under the direction of Gary Keller, D.V.M. This animal care program includes sentinel mice and careful ongoing serological and pathologic surveillance for identification of pathogens. Such surveillance will be critical in the evaluation of lung disease in our various transgenic models and be necessary for the interpretation of genetic vs. environmental effects on lung development and repair following injury.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
1P50HL056387-02
Application #
6242660
Study Section
Project Start
1997-09-01
Project End
1998-08-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Hahn, Andrew D; Higano, Nara S; Walkup, Laura L et al. (2017) Pulmonary MRI of neonates in the intensive care unit using 3D ultrashort echo time and a small footprint MRI system. J Magn Reson Imaging 45:463-471
Korsten, Peter; Strohmayer, Katharina; Baughman, Robert P et al. (2016) Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach. Clin Pulm Med 23:67-75
Lammi, Matthew R; Baughman, Robert P; Birring, Surinder S et al. (2015) Outcome Measures for Clinical Trials in Interstitial Lung Diseases. Curr Respir Med Rev 11:163-174
Wert, Susan E; Whitsett, Jeffrey A; Nogee, Lawrence M (2009) Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 12:253-74
Perl, Anne-Karina T; Gale, Emily (2009) FGF signaling is required for myofibroblast differentiation during alveolar regeneration. Am J Physiol Lung Cell Mol Physiol 297:L299-308
Bridges, James P; Xu, Yan; Na, Cheng-Lun et al. (2006) Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C. J Cell Biol 172:395-407
Bullard, Janine E; Wert, Susan E; Whitsett, Jeffrey A et al. (2005) ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 172:1026-31
Shannon, John M; Hyatt, Brian A (2004) Epithelial-mesenchymal interactions in the developing lung. Annu Rev Physiol 66:625-45
Akeson, A L; Brooks, S K; Thompson, F Y et al. (2001) In vitro model for developmental progression from vasculogenesis to angiogenesis with a murine endothelial precursor cell line, MFLM-4. Microvasc Res 61:75-86
Akeson, A L; Wetzel, B; Thompson, F Y et al. (2000) Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme. Dev Dyn 217:23-Nov